Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account
Code deleted, see 15271-15278

Official Description

Tissue cultured allogeneic skin substitute; each additional 25 sq cm, or part thereof (List separately in addition to code for primary procedure)

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

A tissue cultured allogeneic skin substitute is a specialized medical product used to cover wounds or skin defects. This substitute is designed to promote healing by providing a temporary biological covering that mimics the structure and function of natural skin. The substitute consists of two distinct layers: the upper layer is made up of living human skin cells, specifically cultured from human keratinocytes, which are responsible for forming the epidermal layer of the skin. The lower layer is composed of human dermal fibroblasts, which are also cultured from the same donor, and these fibroblasts are combined with structural proteins, such as collagen, sourced from animals, typically bovine (cow). The application of this skin substitute involves measuring the size of the wound to determine the appropriate amount of tissue cultured allogeneic skin substitute needed. The substitute is fenestrated, meaning that a series of holes or openings are created in it to facilitate fluid drainage and promote integration with the surrounding tissue. Once prepared, the fenestrated skin substitute is applied to the wound bed and secured in place using sutures. To protect the area and support healing, a layered dressing is then applied, which includes a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze for absorption, a compression layer to reduce swelling, and an anti-shear layer to minimize friction. For billing purposes, CPT® Code 15340 is used for the first 25 square centimeters or less of the skin substitute, while CPT® Code 15341 is designated for each additional 25 square centimeters or part thereof.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The tissue cultured allogeneic skin substitute is indicated for use in various clinical scenarios where there is a need to cover a wound or skin defect. The following conditions may warrant the application of this procedure:

  • Wound Coverage The procedure is performed to cover acute or chronic wounds that require a biological dressing to promote healing.
  • Skin Defects It is indicated for skin defects resulting from surgical procedures, trauma, or other medical conditions that compromise the integrity of the skin.
  • Burns The skin substitute is utilized in the treatment of burn injuries, providing a protective layer that aids in recovery.

2. Procedure

The application of a tissue cultured allogeneic skin substitute involves several key procedural steps that ensure effective coverage and healing of the wound. The following steps outline the procedure:

  • Step 1: Wound Assessment The clinician begins by assessing the size and condition of the wound or skin defect. Accurate measurement is crucial to determine the amount of tissue cultured allogeneic skin substitute required for adequate coverage.
  • Step 2: Preparation of the Skin Substitute Once the wound is assessed, the appropriate amount of tissue cultured allogeneic skin substitute is obtained. This substitute is typically fenestrated, which involves creating a series of holes or openings in the material to allow for drainage and integration with the surrounding tissue.
  • Step 3: Application to the Wound Bed The fenestrated skin substitute is then carefully applied to the prepared wound bed. It is important to ensure that the substitute adheres properly to the wound surface to facilitate healing.
  • Step 4: Securing the Substitute After placement, the skin substitute is secured in position using sutures. This step is essential to maintain the integrity of the substitute and prevent displacement during the healing process.
  • Step 5: Dressing Application Following the securement of the skin substitute, a layered dressing is applied. This dressing typically consists of a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze for absorption, a compression layer to manage swelling, and an anti-shear layer to reduce friction and protect the area.

3. Post-Procedure

Post-procedure care is critical to ensure optimal healing and minimize complications. After the application of the tissue cultured allogeneic skin substitute, the patient should be monitored for any signs of infection or adverse reactions. The dressing should be kept clean and dry, and the clinician may provide specific instructions regarding when to change the dressing and how to care for the wound. Follow-up appointments are typically scheduled to assess the healing progress and determine if additional treatments or interventions are necessary. The expected recovery time may vary depending on the size and severity of the wound, as well as the patient's overall health and response to the skin substitute.

Short Descr APPLY CULT SKIN SUB ADD-ON
Medium Descr TISS CLTR ALGC SKN EA 25 CM
Long Descr Tissue cultured allogeneic skin substitute; each additional 25 sq cm, or part thereof (List separately in addition to code for primary procedure)
Status Code Active Code
Global Days ZZZ - Code Related to Another Service
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) none
MUE Not applicable/unspecified.
CCS Clinical Classification 172 - Skin graft
Date
Action
Notes
2012-01-01 Deleted Code deleted, see 15271-15278
2011-01-01 Changed Guideline information changed.
2009-01-01 Changed Code description changed
2006-01-01 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"